Reversible Hypercalcemia in Masculinizing Hypernephroid Tumor of the Ovary

Publisher Website
Google Scholar
Abstract
Hypercalcemia has been recognized as an important complication in patients with neoplastic disease. In a group of patients with miscellaneous cancers, excluding multiple myeloma, studied by Myers,1 8.9 per cent were shown to have had hypercalcemia at one time or another in the course of the disease. This metabolic disturbance may result in rapid deterioration, unexplained mental symptoms or sudden death in such patients.2 Hypercalcemia in malignant lesions with metastases to bone has been well documented. However, lately, this complication has been reported in cases such as carcinoma of the lung, kidney or ovary, without any evidence of metastases to . . .